HIV drug-resistant strains as epidemiologic sentinels

Area of Science:

• Epidemiology
• Mathematical Biology
• Public Health

Background:

• Observed declines in drug resistance to nucleoside reverse transcriptase inhibitors (NRTIs) in recently infected HIV-1 populations could be misinterpreted as a sign to reduce prevention efforts.
• This trend may mask underlying shifts in the epidemic dynamics and public health interventions.

Purpose of the Study:

• To identify and analyze the processes that could explain the observed decline in HIV-1 drug resistance.
• To evaluate the potential impact of these processes on disease and drug resistance prevalence.
• To inform appropriate public health responses based on different epidemic scenarios.

Main Methods:

• Utilized a mathematical modeling approach to simulate HIV-1 transmission and drug resistance.
• Investigated three key processes: changes in high-risk behavior, treatment access for acute infections, and treatment efficacy.
• Analyzed how these factors, individually or combined, influence resistance and disease prevalence.

Main Results:

• Identified three primary drivers for declining drug resistance: increased high-risk behavior, decreased treatment for acute infections, and altered treatment efficacy.
• Demonstrated that these factors can independently or interactively lead to varied outcomes in disease and drug resistance prevalence.
• Highlighted the critical need for ongoing data collection and analysis to accurately interpret trends.

Conclusions:

• Drug resistance markers serve as crucial epidemiologic sentinels for public health.
• Misinterpreting declining resistance trends could lead to premature reduction in HIV prevention efforts.
• A nuanced public health strategy is required, considering multiple factors influencing HIV resistance and prevalence.